Desmistificando o Diagnóstico e Manejo da Osteodistrofia Hepática na Colestase e Outras Hepatopatias

uma revisão

Authors

  • Liliana Sampaio Costa Mendes IHBDF

DOI:

https://doi.org/10.51723/ccs.v29i03.214

Keywords:

Cirrhosis, Osteoporosis, Osteopenia

Abstract

Hepatic osteodystrophy (OH) involves the presence of osteoporosis, osteopenia, or, less frequently, osteomalacia that affects liver disease and this term is very controversial. There is a lack of consensus in the literature on what is considered liver disease in this context. Chronic liver disease is associated with increased bone loss. In Brazil, the first bone densitometry is indicated at more advanced ages and cirrhosis is not considered as a risk factor for osteopenia and osteoporosis. We have to worry about low bone mineral density not only in chronic liver disease but especially in cirrhosis, especially if cholestasis is the cause. It is necessary to estimate the bone mass and to act before a possible liver transplant, since this would bring even more deleterious consequences to the bone mass due to the incorporated use of corticosteroids during the immunosupression. The purpose of this article is to demystify the conduction of the investigation and treatment of OH in cholestatic and non - cholestatic liver diseases, through literature review.

Downloads

Download data is not yet available.

References

Published

2019-04-29

Issue

Section

Clínica Assistencial

How to Cite

1.
Desmistificando o Diagnóstico e Manejo da Osteodistrofia Hepática na Colestase e Outras Hepatopatias: uma revisão. Com. Ciências Saúde [Internet]. 2019 Apr. 29 [cited 2026 Feb. 11];29(03). Available from: https://revistaccs.espdf.fepecs.edu.br/index.php/comunicacaoemcienciasdasaude/article/view/214